search
Back to results

Familien-SCOUT: Comprehensive Support for Families With a Parent Suffering From Cancer (F-SCOUT)

Primary Purpose

Families With Minor Children and One Parent Suffering From Cancer

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
F-SPOKE
Sponsored by
RWTH Aachen University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Families With Minor Children and One Parent Suffering From Cancer

Eligibility Criteria

8 Years - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Confirmed ICD diagnosis of cancer in one parent
  • Custody of at least one underage child
  • Adequate knowledge of German
  • Availability of informed consent to participate in the study from the patient and/or healthy parent and linkage to questionnaire data and routine data

Exclusion Criteria:

  • Withdrawal of consent by the ill or healthy parent
  • Relevant cognitive limitation, advanced dementia
  • Individuals who are in relationships of dependence or employment to the project managers or their representatives

Sites / Locations

  • Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University
  • Department of Psychosomatic Medicine and Psychotherapy, University Hospital Bonn
  • Clinical Institute of Psychosomatic Medicine and Psychotherapy, Heinrich-Heine-University Duesseldorf

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention group (IG)

Control Group

Arm Description

Families receive permanent contact persons to support in the organisation of everyday life, financial applications, during emotional coping with illness and open communication within the family.

In the control group the families are treated according to the standard of care.

Outcomes

Primary Outcome Measures

Hospital Anxiety and Depression Scale (HADS
HADS is used to record anxiety and depression in patients with physical diseases or psychogenic physical symptoms.Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression. The HADS uses a scale and therefore the data returned from the HADS is ordinal.

Secondary Outcome Measures

Distress Thermometer (DT)
DT is a screening instrument developed by the National Comprehensive Cancer Network (NCCN) for registering psychosocial stress in oncological patients. It consists of a scale from 0 to 10 and a list of problems, providing a scheme for referral to the relevant professional services.
Parenting Concerns Questionnaire (PCQ)
PCQ is used to record concerns among parents who have developed cancer. It includes 15 items with a 5-level response scale.
HLS-EU-Q16
HLS-EU-Q16 measures health competenceliteracy, using 16 items and a four-level response scale.
PA-F-P-KF
The short form of the Fear of Progression Anxiety Questionnaire for Partners (PA-F-P-KF) records anxieties regarding progression fear of progression in healthy partners of individuals with chronic disease. The scale includes 12 items, each with a 5-level scale of response categories.
CaPIN
The Cancer Patient Information Needs (CaPIN) scale measures information needs on various topics among cancer patients. The scale consists of 22 items with binary-coded response categories (yes/no).
MOS-SS
This instrument is a subscale of the validated "Medical Outcomes Study Social Support (MOS-SS) survey. The eight items on the subscale record emotional and informational social support. The response categories have a five-level scale.
FAD
The Family Assessment Device (FAD)is based on the McMaster Model of Family Functioning (MMFF), a clinically oriented conceptualization of families. It is a screening instrument only consisting of 53-items. The model identifies six dimensions of family functioning. Scores range from 1 to 4 with 1 reflecting healthy functioning and 4 reflecting unhealthy functioning. The FAD is made up of seven scales.
EQ-5D-5L
The EuroQoL Group (EQ)-5D is a generic measurement instrument that uses a standardized, preference-based procedure to describe and investigate health-related quality of life.The EQ-5D-5L is composed of the EQ-5D-5L descriptive system and the EQ Visual Analogue scale (EQ VAS). The descriptive system comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression). Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Each level corresponds to 1-digit number expressing the level selected for that dimension.
KIDSCREEN-10:
The KIDSCREEN questionnaire for children is used to record health-related quality of life (HRQoL). The scale ranges from 5 to 50, with a higher score indicating a better quality of life.

Full Information

First Posted
December 2, 2019
Last Updated
October 25, 2022
Sponsor
RWTH Aachen University
search

1. Study Identification

Unique Protocol Identification Number
NCT04186923
Brief Title
Familien-SCOUT: Comprehensive Support for Families With a Parent Suffering From Cancer
Acronym
F-SCOUT
Official Title
Familien-SCOUT: Comprehensive Support for Families With a Parent Suffering From Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Completed
Study Start Date
October 1, 2019 (Actual)
Primary Completion Date
September 1, 2021 (Actual)
Study Completion Date
June 1, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
RWTH Aachen University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
When a parent with minor children falls ill with cancer, it is extremely stressful for all of the family members, including the partner and children. Familiar everyday routines are often disrupted even at an early stage, and for a prolonged period. Financial difficulties, the threat represented by the uncertain course of the disease, and worries about the children's future have a cumulative effect. The affected families are thereby pushed to their limits organizationally and emotionally. The burden involved tends to be underestimated, and secondary psychological conditions often develop among all the family members. They often do not have adequate access to support. The aim of this project is to establish a care management system that provides support for families with underage children in which one parent is seriously ill. In order to reduce the burden on families, "family SCOUTS" are to be used who can provide advice and information at an early stage. They are intended to encourage families to discuss things openly, and they should also facilitate access to all the support services available. The project will evaluate whether the use of family SCOUTS reduces the burden on the family in comparison with families who do not have a family SCOUT. For this purpose, investigations will be carried out before and after the family SCOUTS are deployed. Standardized questionnaires, interviews, and routine data from the participating health-insurance companies will provide the basic data.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Families With Minor Children and One Parent Suffering From Cancer

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
472 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention group (IG)
Arm Type
Experimental
Arm Description
Families receive permanent contact persons to support in the organisation of everyday life, financial applications, during emotional coping with illness and open communication within the family.
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
In the control group the families are treated according to the standard of care.
Intervention Type
Other
Intervention Name(s)
F-SPOKE
Intervention Description
This project includes communicative, emotional, and also organizational support with outreach across different sectors and phases (F-SPOKE - family-centered, cross-sector and cross-phase organizational, communicative, and emotional support).
Primary Outcome Measure Information:
Title
Hospital Anxiety and Depression Scale (HADS
Description
HADS is used to record anxiety and depression in patients with physical diseases or psychogenic physical symptoms.Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression. The HADS uses a scale and therefore the data returned from the HADS is ordinal.
Time Frame
Change from Baseline HADS at 9 months
Secondary Outcome Measure Information:
Title
Distress Thermometer (DT)
Description
DT is a screening instrument developed by the National Comprehensive Cancer Network (NCCN) for registering psychosocial stress in oncological patients. It consists of a scale from 0 to 10 and a list of problems, providing a scheme for referral to the relevant professional services.
Time Frame
baseline & 9 month
Title
Parenting Concerns Questionnaire (PCQ)
Description
PCQ is used to record concerns among parents who have developed cancer. It includes 15 items with a 5-level response scale.
Time Frame
baseline and 9 month
Title
HLS-EU-Q16
Description
HLS-EU-Q16 measures health competenceliteracy, using 16 items and a four-level response scale.
Time Frame
3 month
Title
PA-F-P-KF
Description
The short form of the Fear of Progression Anxiety Questionnaire for Partners (PA-F-P-KF) records anxieties regarding progression fear of progression in healthy partners of individuals with chronic disease. The scale includes 12 items, each with a 5-level scale of response categories.
Time Frame
baseline & 9 month
Title
CaPIN
Description
The Cancer Patient Information Needs (CaPIN) scale measures information needs on various topics among cancer patients. The scale consists of 22 items with binary-coded response categories (yes/no).
Time Frame
3 & 9 Month
Title
MOS-SS
Description
This instrument is a subscale of the validated "Medical Outcomes Study Social Support (MOS-SS) survey. The eight items on the subscale record emotional and informational social support. The response categories have a five-level scale.
Time Frame
3 month
Title
FAD
Description
The Family Assessment Device (FAD)is based on the McMaster Model of Family Functioning (MMFF), a clinically oriented conceptualization of families. It is a screening instrument only consisting of 53-items. The model identifies six dimensions of family functioning. Scores range from 1 to 4 with 1 reflecting healthy functioning and 4 reflecting unhealthy functioning. The FAD is made up of seven scales.
Time Frame
baseline & 9 month
Title
EQ-5D-5L
Description
The EuroQoL Group (EQ)-5D is a generic measurement instrument that uses a standardized, preference-based procedure to describe and investigate health-related quality of life.The EQ-5D-5L is composed of the EQ-5D-5L descriptive system and the EQ Visual Analogue scale (EQ VAS). The descriptive system comprises 5 dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression). Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Each level corresponds to 1-digit number expressing the level selected for that dimension.
Time Frame
baseline, 3 & 9 month
Title
KIDSCREEN-10:
Description
The KIDSCREEN questionnaire for children is used to record health-related quality of life (HRQoL). The scale ranges from 5 to 50, with a higher score indicating a better quality of life.
Time Frame
baseline & 9 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Confirmed ICD diagnosis of cancer in one parent Custody of at least one underage child Adequate knowledge of German Availability of informed consent to participate in the study from the patient and/or healthy parent and linkage to questionnaire data and routine data Exclusion Criteria: Withdrawal of consent by the ill or healthy parent Relevant cognitive limitation, advanced dementia Individuals who are in relationships of dependence or employment to the project managers or their representatives
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tim H. Brümmendorf, Prof. Dr.
Organizational Affiliation
Department of Hematology, Oncology, Hemostaseology, RWTH Aachen University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University
City
Aachen
Country
Germany
Facility Name
Department of Psychosomatic Medicine and Psychotherapy, University Hospital Bonn
City
Bonn
Country
Germany
Facility Name
Clinical Institute of Psychosomatic Medicine and Psychotherapy, Heinrich-Heine-University Duesseldorf
City
Duesseldorf
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34526078
Citation
Dohmen M, Petermann-Meyer A, Blei D, Bremen R, Brock-Midding E, Brune M, Geiser F, Haastert B, Halbach SM, Heuser C, Holsteg S, Heier L, Icks A, Karger A, Montalbo J, Nakata H, Panse J, Rottmann TP, Sattler K, Viehmann A, Vomhof M, Ernstmann N, Brummendorf TH. Comprehensive support for families with parental cancer (Family-SCOUT), evaluation of a complex intervention: study protocol for a non-randomized controlled trial. Trials. 2021 Sep 15;22(1):622. doi: 10.1186/s13063-021-05577-y.
Results Reference
derived

Learn more about this trial

Familien-SCOUT: Comprehensive Support for Families With a Parent Suffering From Cancer

We'll reach out to this number within 24 hrs